Schizophrenia study combining injections and training ends early with just one participant
NCT ID NCT05662306
First seen Feb 06, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study aimed to help people with early schizophrenia by combining long-acting injectable antipsychotic medication with cognitive and functional skills training. Researchers wanted to see if this approach could lead to symptom remission and better daily functioning. The study was terminated early and only enrolled one participant, so no meaningful conclusions can be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jackson Memorial Hospital
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.